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Ethnic origin is one of the factors that may modulate the prevalence and expression of systemic lupus erythematosus (SLE). It was noted that SLE is more common among black and oriental subjects than white subjects.' 2 Several publications consider this question, and most of them report incidence, prevalence, and mortality due to SLE among various ethnic groups. 3 Relatively little is known, however, about the expression of the disease in patients of different origin.
To consider this question we investigated disease expression in a group of Israeli patients with SLE of Ashkenazi and Sephardic origin.
Patients and methods Data on patients with SLE followed up at the Beilinson Medical Center and diagnosed according to the 1982 American Rheumatism Association (ARA) criteria for SLE4 were evaluated. Information gathered at each visitpatient's history and physical examinationwas entered prospectively into a computerised database. Data were immediately converted by the examining doctor into 25 history and 29 physical examination variables, all on a scale of 0-3 (none, mild, moderate, severe). Patients were assessed by one of three doctors of the rheumatology unit.
RELATION BETWEEN ETHNIC ORIGIN AND DISEASE MANIFESTATIONS
Patients were divided into two groups according to their Ashkenazi or non-Ashkenazi (Sephardic) origin. Patients of mixed Ashkenazi-Sephardic origin and patients of Arabic origin were not included. The Sephardic group was subdivided into those from the Mediterranean area, Iran-Iraq-India, and Yemen. Patients of mixed Sephardic origin were not included in this subdivision. Groups were compared for the various disease variables. For each patient the maximum observed value for variables was recorded, and group medians were compared for each variable.
STATISTICAL EVALUATION
Group interval and ordinal data were compared by Wilcoxon's rank sum test and analysis of variance with paired t test. Nominal data were compared by the x2 test. Multiple linear regression analysis was used to investigate the relation between variables. Significance was not adjusted for multiple comparisons. Data are presented as mean (standard error of the mean).
Results
Of the 90 patients with SLE followed up at our centre, three of mixed Ashkenazi-Sephardic origin and three of Arabic origin were withdrawn from the study. The remaining 84 patients included 39 (46%) of Ashkenazi origin and 45 (54%) of Sephardic origin (table 1) . Sex distribution was similar in both groups (5/39 v 3/45 men, p=0 5). The Ashkenazi group was older (46-9 (2-6) v 40 9 (2-2) years, p=009) and had a significantly higher level of education (13-0 (0 5) v 9 9 (0 6) years of schooling, p<0 001). The Ashkenazi patients were seen (1-0) times during 654 (68) days compared with (0-6) times during 746 (47) days for the Sephardic patients (p=05 for times, p=0-8 for days). Repeat assessment was conducted for 36/39 Ashkenazi patients and 42/45 Sephardic patients.
RELATION BETWEEN ETHNIC ORIGIN AND DISEASE MANIFESTATIONS
The Sephardic group had more serious disease manifestations for 60/76 (79%) clinical and laboratory variables examined. These were significant for alopecia and muscle tenderness by both patient history and physical examination, and for cutaneous vasculitis, antibodies to DNA, C3 complement, erythrocyte sedimentation rate, and white blood cell count. Only pericarditis had a significantly higher value in the Ashkenazi group (table 2) .
The Sephardic group had higher creatinine concentrations (117-6 (15-9) v 93-7 (5 3) jmol/l, p=04) and higher prevalence df renal disease (35-6% v 28&2%, p=0 6). Central nervous system manifestations of psychosis, convulsions, or organic brain symptoms were monitored in 14 (31%) of Sephardic patients and 15 (38%) of Ashkenazi patients (p=0 6). In the Sephardic group 28 (62%) had rash and eight (18%) discoid rash compared with 21 (54%) and five (13%) respectively in the Callahan and Pincus reported that clinical status was poorer in patients with SLE with low education level. '4 We showed that most of the differences between the Ashkenazi and Sephardic patient groups persisted when patients were divided according to equal education level, except that Sephardic patients with a higher education had relatively milder disease. The Yemenite patient group, which had the most severe disease indices, did not differ from the other Sephardic groups in education or age. Multivariate analysis indicated that origin is the cardinal factor in the clinical differences between our patients. Thus although education and age have some importance in the expression of SLE, their contribution seems to be relatively minor.
The higher severity of disease in the Sephardic patients could theoretically have been due to the fact that well educated Ashkenazi patients, possibly those with mild disease, may present earlier or get referrals more easily. Yet, when patients with equal education level were compared the Sephardic patients still had more severe disease expression. Thus this factor does not seem to constitute a significant bias in our study.
Hochberg investigated and extensively reviewed the epidemiology of SLE.3 Black patients in the United States had about a threefold higher incidence of SLE than white patients.'5 16 He also discussed the effects of race on morbidity rates, and black subjects in the United States again had about a threefold prevalence of SLE in comparison with white subjects.15 178 These differences in incidence and prevalence were manifest for both men and women. Systemic lupus erythematosus was more prevalent among oriental than white subjects in Hawaii"9 20 and New Zealand,2' and more prevalent among Asian than white subjects in England.22 Also, the mortality of black subjects with SLE was significantly higher than that for white subjects for both men and women. 12 15 [23] [24] [25] [26] Less is known about expression of the disease in the various races. Fessel compared data of white and black patients with SLE in San Francisco according to diagnostic criteria.'7 As mentioned, the disease was more prevalent among black patients, who also had more haematological abnormalities and serositis, whereas non-black patients had more malar rash and convulsions/psychosis. Ginzler et al noted that black patients with SLE developed more severe renal, haematological, and central nervous system disease over a shorter period of time. " When data were corrected for socioeconomic status, race did not significantly influence survival. Ward and Studenski compared black subjects with white subjects according to the revised ARA criteria27 and found that black subjects had a higher incidence of antibodies to Sm and RNP, more discoid rash and proteinuria, and, less commonly, photosensitivity. Samanta et al compared Asian patients and white patients with SLE in Britain.22 Asian patients had more renal disease, neuropsychiatric features, myalgic symptoms, and higher antinuclear antibodies and extractable nuclear antigens.
From the above data a trend can be seen of higher incidence and prevalence of disease, higher mortality, and more severe disease expression in the non-white races. This is in accordance with our observation of a more severe disease expression among Sephardic Israeli patients with SLE. The explanation for this difference is unclear, but several suggestions can be made. Systemic lupus erythematosus is known to be related to female sex hormones.28 Japanese and Bantu girls and young women were found to have a higher level of 17 3-oestradiol than white women.29 Thus hormonal differences might explain the difference between races for the prevalence and expression of SLE.
Genetic heterogeneity might be another explanation. HLA-DR2, DR3, and DQwl as well as the complement components located in the HIA system have been reported in association with SLE.3 Thus genetic differences between patient subgroups could be the basis for the clinical differences. Genetic markers were investigated in various Jewish populations,30 and Ashkenazi, North African, and Iraqi Jewish populations were found to be consistently close in genetic constitution and distant from Yemenite Jews, Arabs, and nonJewish German and Russian populations. This may be understood in accordance with our observation of more severe disease expression among our Yemenite patients. However, the above mentioned HLA-DR and complement alleles were not examined in this study.
In conclusion, our study shows differences between Israeli Jewish lupus patients of various ethnic origins. These findings may have implications on SLE research. Owing to the apparent difference between lupus patients of various origins, research in such patients should be stratified accordingly. Future studies should highlight prevalence and mortality among Jewish SLE patients, and further investigation of the HLA phenotypes of these groups may help to explain our findings and contribute towards better understanding of the pathogenesis of SLE. 
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